These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 1698251

  • 1. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M, Lignon MF, Galas MC, Amblard M, Martinez J.
    Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
    [Abstract] [Full Text] [Related]

  • 2. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP.
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors.
    Rodriguez M, Amblard M, Galas MC, Lignon MF, Aumelas A, Martinez J.
    Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
    Galas MC, Lignon MF, Rodriguez M, Mendre C, Fulcrand P, Laur J, Martinez J.
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G176-82. PubMed ID: 2450468
    [Abstract] [Full Text] [Related]

  • 9. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ, Vaughn LK, Fang SN, Bogert CL, Yamamura MS, Hruby VJ, Yamamura HI.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [Abstract] [Full Text] [Related]

  • 10. Novel CCK analogues and bombesin: a detailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secretion in three rodent species.
    Bianchi BR, Miller TR, Witte DG, Lin CW.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):996-1002. PubMed ID: 7509394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M, Galas MC, Lignon MF, Mendre C, Laur J, Aumelas A, Martinez J.
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M, Lignon MF, Galas MC, Fulcrand P, Mendre C, Aumelas A, Laur J, Martinez J.
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
    Lin CW, Bianchi BR, Grant D, Miller T, Danaher EA, Tufano MD, Kopecka H, Nadzan AM.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):729-34. PubMed ID: 2419543
    [Abstract] [Full Text] [Related]

  • 17. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 18. A pseudopeptide that is a potent cholecystokinin agonist in the peripheral system is able to inhibit the dopamine-like effects of cholecystokinin in the striatum.
    Mendre C, Rodriquez M, Gueudet C, Lignon MF, Galas MC, Laur J, Worms P, Martinez J.
    J Biol Chem; 1988 Aug 05; 263(22):10641-5. PubMed ID: 3392031
    [Abstract] [Full Text] [Related]

  • 19. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D.
    Mol Pharmacol; 1994 Apr 05; 45(4):599-607. PubMed ID: 8183238
    [Abstract] [Full Text] [Related]

  • 20. Cyclic cholecystokinin analogues with high selectivity for central receptors.
    Charpentier B, Pelaprat D, Durieux C, Dor A, Reibaud M, Blanchard JC, Roques BP.
    Proc Natl Acad Sci U S A; 1988 Mar 05; 85(6):1968-72. PubMed ID: 3162318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.